Alessio Branchini Shares His Latest Work on Albumin-Fused Factor IX Variants and Thanks The Whole Team
Alessio Branchini, Associate Professor of Molecular Biology at University of Ferrara, shared on LinkedIn:
”Very proud to announce that our paper is published!
Great and hard, but exciting, work on the characterization and biodistribution of engineered albumin-fused factor IX variants with tailored biinding to extravascular collagen.
Wonderful collaborations involving our group at the University of Ferrara, the team at the University of Oslo and the San Raffaele Hospital.
From the University of Ferrara side, excellent work by Maria Francesca Testa, Rebecca Tarantino and Mascia Benedusi.
Very thankful to Jan Terje Andersen, Kristin Hovden Aaen and Jeannette Nilsen (University of Oslo for the wonderful and ongoing collaboration (10 years!), to Alessio Cantore and Cesare Canepari (Ospedale San Raffaele) for their extremely valuable contribution, as well as to all collaborators.
Together we made this story possible.
Of course, a particular thank you to my (and our) mentors Francesco Bernardi and Mirko Pinotti at the University of Ferrara.
Last but not least, I am really grateful to the Access to Insight Basic Research Grant program by Novo Nordisk.
Press releases on Eurekalert and on the news site of University of Ferrara.”
Read the full article in Nature Communications.
Article: Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties
Authors: Kristin Hovden Aaen, Maria Francesca Testa, Jeannette Nilsen, Rebecca Tarantino, Cesare Canepari, Mascia Benedusi, Sopisa Benjakul, Mari Nyquist-Andersen, Marie Leangen Herigstad, Alessio Cantore, Giuseppe Valacchi, Inger Sandlie, Francesco Bernardi, Mirko Pinotti, Alessio Branchini, Jan Terje Andersen
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 4, 2025, 10:26Gaetan Duport about HTA and Reimbursement Models in Treatments for Bleeding Disorders
-
Oct 3, 2025, 16:31Ronit Kar and Team Used Microfluidic Technology and Found That Platelets From Pediatric Trauma
-
Oct 3, 2025, 07:53Pancytopenia in Pregnancy: A Time-Critical Hematological Emergency
-
Oct 2, 2025, 14:12Helen McPherson at ISFP-IFRS 2025: Fibrin Clot Structure and Function Modulation by Targeting Fibrinogen aC Region
-
Oct 2, 2025, 10:48Kanishk Kumar: TFPI Market Size - Advancing Hemostasis and Antithrombotic Therapy
-
Oct 4, 2025, 10:23Read Jamie Madrigal, Dougald Monroe, Suzanne Sindi and Karin Leiderman's Latest Analysis on Emicizumab
-
Oct 4, 2025, 10:19Alexandre Kauskot Thanks Marie A Hollenhorst on Her Editorial On His Recent Publication on Platelet Glycotime
-
Oct 4, 2025, 10:10Alessio Branchini Shares His Latest Work on Albumin-Fused Factor IX Variants and Thanks The Whole Team
-
Oct 3, 2025, 16:37Steven Murphy Highlights New Research Linking POTS Platelets to Storage Pool Deficiency
-
Oct 3, 2025, 16:33Roberta Gualtierotti and Jacopo Acquati Lozej Will Explore Strategies to Preserve Joint Health
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 2, 2025, 04:572025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
-
Oct 1, 2025, 15:59Anirban Sen Gupta: Thrilled to share a great collaboration story in Nature Portfolio
-
Oct 4, 2025, 10:21Maria Elisa Mancuso: Chance to Listen to Inspiring Experiences of People Who Live With Bleeding Disorders
-
Oct 4, 2025, 10:04Stéphanie Roullet Gave Talk on Platelet-Inspired Nanoparticles at SFTH 2025 Congress
-
Oct 4, 2025, 09:55NBDF: Proud to See Our Own Teri F Willey Representing the Foundation in the Funding Rare Disease Research Webinar
-
Oct 4, 2025, 09:49Emmanuel J Favaloro: Promoting World Thrombosis Day Whilst Giving a Talk in Tasmania
-
Oct 3, 2025, 14:48Maha Othman - Elected as the Co-Lead for the Basic and Translational Research Platform at CanVECTOR Research Network